Patents by Inventor Hemant Varma

Hemant Varma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agents For Treating Neurodegenerative Diseases
    Publication number: 20070149543
    Abstract: The present invention relates to compounds effective in preventing neuronal cell death, which may be used in the treatment of neurodegenerative diseases. It is based, at least in part, on the discovery that particular compounds were effective in preventing neuronal death in model systems of Huntington's Disease.
    Type: Application
    Filed: December 18, 2006
    Publication date: June 28, 2007
    Inventors: Brent Stockwell, Benjamin Hoffstrom, Hemant Varma
  • Agents for treating neurodegenerative diseases
    Publication number: 20070078144
    Abstract: The present invention relates to compounds effective in preventing neuronal cell death, which may be used in the treatment of neurodegenerative diseases. It is based, at least in part, on the discovery that particular compounds were effective in preventing neuronal death in model systems of Huntington's Disease.
    Type: Application
    Filed: August 2, 2006
    Publication date: April 5, 2007
    Inventors: Brent Stockwell, Benjamin Hoffstrom, Hemant Varma
  • Agents for treating neurodegenerative diseases
    Publication number: 20070027164
    Abstract: The present invention relates to compounds effective in preventing neuronal cell death, which may be used in the treatment of neurodegenerative diseases. It is based, at least in part, on the discovery that particular compounds were effective in preventing neuronal death in model systems of Huntington's Disease.
    Type: Application
    Filed: February 7, 2006
    Publication date: February 1, 2007
    Inventors: Brent Stockwell, Benjamin Hoffstrom, Hemant Varma
  • Identification of genotype-selective agents for treating Huntington's disease
    Publication number: 20050032124
    Abstract: The present invention relate to methods of identifying a genotype-selective agent. In certain embodiments, the invention relates to agents that selectively suppress huntingtin-induced toxicity to engineered neuronal cells.
    Type: Application
    Filed: January 29, 2004
    Publication date: February 10, 2005
    Inventors: Brent Stockwell, Benjamin Hoffstrom, Hemant Varma